ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In summary, the result of this study demonstrates that NGS is more sensitive than Sanger sequencing method for detecting BCR::ABL1 KD mutations in CML patients, thus emphasizing the crucial role of NGS assays in advancing the understanding of mutation-associated TKI resistance in CML.